At Memphasys Limited, we are proud to announce a major breakthrough in biotechnology with the filing of a patent for our cutting-edge antioxidant assay system, RoXsta™. This pioneering innovation is set to transform the way oxidative stress is measured, offering groundbreaking advancements for industries ranging from healthcare to food quality control.
Understanding Oxidative Stress and Its Importance
Oxidative stress occurs when there is an imbalance between harmful reactive oxygen species (ROS) and the body’s natural ability to neutralise them with antioxidants. This imbalance is associated with a variety of health concerns, including ageing, chronic diseases, and fertility challenges in both humans and animals. As a result, managing oxidative stress has become critical for improving diagnostics in areas such as reproductive health and chronic disease management.
Traditionally, testing for oxidative stress has been a complex and time-consuming process, requiring extensive laboratory analysis. With RoXsta™, we are excited to offer a faster, more accessible solution. Soon, healthcare professionals, fertility specialists, and researchers will be able to measure oxidative stress in various fluids—such as blood, urine, semen, and even food extracts—in just six minutes.
A Breakthrough in Speed and Accessibility
One of the most remarkable features of the RoXsta™ system is its ability to deliver results significantly faster than traditional methods. While conventional assays can take hours or even days, RoXsta™ produces accurate readings within six minutes, enabling real-time decision-making. This leap in efficiency is particularly valuable in areas such as fertility assessments, where timely interventions are essential.
While RoXsta™ is not yet a fully integrated point-of-care device, Memphasys has developed a working prototype that operates in a laboratory setting with the assistance of a technician. However, the potential for evolving this technology into a fully functional, user-friendly point-of-care device is vast. We are actively engaging with industry partners to secure the investment necessary for this next stage of development.
Future Potential and Industry Engagement
Memphasys is already conducting field tests with our RoXsta™ prototype, which has shown highly promising results. Additionally, we are preparing for an industry-backed study to establish baseline oxidative stress levels and thresholds, helping to refine the system’s accuracy and applicability. This research aims to identify important correlations between oxidative stress levels and factors like reproductive performance.
To further solidify RoXsta™’s scientific foundation, Memphasys is preparing a series of publications detailing the technical aspects and validation of the system across multiple diagnostic fields. These papers will cover topics ranging from male infertility to processed fruit quality, underscoring the versatility and broad applicability of the RoXsta™ system.
RoXsta™: A Game-Changer for Diagnostics
With the RoXsta™ system, Memphasys is positioned to lead the way in oxidative stress measurement and management, offering industries a faster, more efficient tool. As we work toward developing a fully integrated point-of-care device, the potential applications for RoXsta™ are extensive. Whether in fertility clinics, research labs, or food quality testing facilities, we believe this innovative system will soon become a vital part of modern diagnostics.
As we continue to advance RoXsta™, Memphasys remains committed to delivering cutting-edge solutions supported by rigorous science. With this patent filing, we have solidified our position at the forefront of this rapidly evolving field, offering the potential to improve outcomes across healthcare and beyond.